RecruitingNCT04959097

Retinoblastoma Patient Clinical Database and Tissue Repository

Sponsor

Children's Hospital Los Angeles

Enrollment

800 participants

Start Date

Jan 1, 2017

Study Type

OBSERVATIONAL

Conditions

Retinoblastoma Retinoblastoma Bilateral Retinoblastoma Unilateral

Summary

Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB is diagnosed without a biopsy; tumor can only be studied once an eye has been surgically removed. Given this limitation, we use aqueous humor (AH), the clear fluid in the front of the eye to detect specific markers, or information, that comes from the tumor itself.

Eligibility

Min Age: 0 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with retinoblastoma, retinoblastoma bilateral, and other related conditions. The study is currently recruiting participants at 9 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.